NCT01768481View on ClinicalTrials.gov

Intima Media Thickness Regression in Dyslipidemic Teenagers

PHASE3CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

December 31, 2009

Study Completion Date

June 30, 2010

Conditions

ObesityDyslipidemia

Interventions

DRUG

Atorvastatin

10 mg Atorvastatin vs placebo daily in a randomized controlled trial for one year

DRUG

sugar pill

placebo controlled arm receives similarly looking placebo.

Trial Locations (1)

H1T 2M4

Hôpital Maisonneuve-Rosemont, Montreal

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Université de Montréal

OTHER